Back

Ex Vivo Immune Profiling Defines a Continuous Functional Immune Axis and a Sepsis-Enriched Low-Response State in Critical Illness

Brown, R.-A.; Bonavia, A. S.

2026-04-29 intensive care and critical care medicine
10.64898/2026.04.28.26351971 medRxiv
Show abstract

BackgroundImmune dysfunction in sepsis and critical illness is biologically heterogeneous, yet available stratification frameworks leave many patients unclassified. We hypothesized that ex vivo cytokine-induction responses would define a continuous axis of functional immune responsiveness and identify a low-response state enriched in sepsis. MethodsIn this prospective observational study, 39 critically ill adults enrolled within 48 hours of ICU admission and 6 healthy controls underwent standardized whole-blood stimulation with lipopolysaccharide, anti-CD3/anti-CD28 antibodies, and PMA/ionomycin, with selected wells additionally supplemented with interleukin-7 or granulocyte-macrophage colony-stimulating factor. Interleukin-6, tumor necrosis factor, and interferon-gamma responses were quantified and referenced to subject-specific unstimulated baselines. A patient-anchored primary feature matrix was used to derive a continuous immune axis by principal component analysis, and a cross-validated 5-feature MiniResponder score was developed as a portable summary measure. ResultsAmong critically ill patients, induced cytokine responses organized along a dominant continuous axis of functional immune responsiveness; the first principal component explained 53.3% of between-patient variance. MiniResponder captured this axis and showed a lower-shifted distribution in sepsis. Using a control-referenced threshold defined by the 10th percentile of the healthy-control distribution, 19 of 39 patients (48.7%) were classified as low-response, including 15 of 21 patients with sepsis (71.4%) and 4 of 18 critically ill patients without sepsis (22.2%) (odds ratio 8.75, Fisher exact P=0.004). In exploratory analyses, lower MiniResponder scores were associated with greater unadjusted improvement in Sequential Organ Failure Assessment score from day 1 to days 3-9 (rho=-0.33; P=0.046), but this association attenuated after adjustment for baseline SOFA score (beta=-0.10; 95% CI-0.36 to 0.27). ConclusionsEx vivo immune profiling identified a continuous patient-anchored axis of functional immune responsiveness in critical illness that can be summarized by a compact 5-feature score. A control-referenced low-response state was enriched in sepsis. This framework may complement existing biomarker-based stratification approaches and support future enrichment strategies in sepsis trials.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Scientific Reports
3612 papers in training set
Top 3%
11.8%
2
PLOS ONE
5266 papers in training set
Top 25%
6.7%
3
Critical Care
15 papers in training set
Top 0.1%
6.7%
4
Frontiers in Immunology
638 papers in training set
Top 2%
6.7%
5
Critical Care Explorations
14 papers in training set
Top 0.1%
6.7%
6
JCI Insight
277 papers in training set
Top 1%
5.4%
7
Critical Care Medicine
12 papers in training set
Top 0.1%
4.8%
8
The Journal of Infectious Diseases
202 papers in training set
Top 0.7%
4.8%
50% of probability mass above
9
Science Translational Medicine
127 papers in training set
Top 0.6%
3.2%
10
Frontiers in Medicine
120 papers in training set
Top 1%
3.2%
11
eBioMedicine
183 papers in training set
Top 1.0%
3.2%
12
Journal of Leukocyte Biology
42 papers in training set
Top 0.2%
2.6%
13
iScience
1154 papers in training set
Top 11%
2.4%
14
npj Digital Medicine
118 papers in training set
Top 2%
2.1%
15
Wellcome Open Research
67 papers in training set
Top 0.5%
2.1%
16
Nature Communications
5641 papers in training set
Top 42%
2.1%
17
European Respiratory Journal
59 papers in training set
Top 0.7%
1.4%
18
American Journal of Respiratory and Critical Care Medicine
43 papers in training set
Top 0.6%
1.1%
19
Journal of Clinical Medicine
97 papers in training set
Top 4%
1.1%
20
British Journal of Anaesthesia
17 papers in training set
Top 0.3%
1.1%
21
Clinical Chemistry
22 papers in training set
Top 0.3%
0.8%
22
Frontiers in Cellular and Infection Microbiology
109 papers in training set
Top 4%
0.8%
23
BMJ Open
601 papers in training set
Top 13%
0.8%
24
Nature Medicine
125 papers in training set
Top 3%
0.8%
25
Immunity, Inflammation and Disease
10 papers in training set
Top 0.5%
0.6%
26
PLOS Computational Biology
1863 papers in training set
Top 22%
0.6%
27
BMC Medicine
176 papers in training set
Top 6%
0.6%
28
Heliyon
152 papers in training set
Top 9%
0.6%